These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


108 related items for PubMed ID: 11020466

  • 1. Particle size analysis of high density lipoproteins in patients with genetic cholesteryl ester transfer protein deficiency.
    Arai T, Tsukada T, Murase T, Matsumoto K.
    Clin Chim Acta; 2000 Nov; 301(1-2):103-17. PubMed ID: 11020466
    [Abstract] [Full Text] [Related]

  • 2. Familial cholesteryl ester transfer protein deficiency is associated with triglyceride-rich low density lipoproteins containing cholesteryl esters of probable intracellular origin.
    Bisgaier CL, Siebenkas MV, Brown ML, Inazu A, Koizumi J, Mabuchi H, Tall AR.
    J Lipid Res; 1991 Jan; 32(1):21-33. PubMed ID: 2010691
    [Abstract] [Full Text] [Related]

  • 3. Polydisperse low-density lipoproteins in hyperalphalipoproteinemic chronic alcohol drinkers in association with marked reduction of cholesteryl ester transfer protein activity.
    Hirano K, Matsuzawa Y, Sakai N, Hiraoka H, Nozaki S, Funahashi T, Yamashita S, Kubo M, Tarui S.
    Metabolism; 1992 Dec; 41(12):1313-8. PubMed ID: 1461137
    [Abstract] [Full Text] [Related]

  • 4. Molecular biology and pathophysiological aspects of plasma cholesteryl ester transfer protein.
    Yamashita S, Hirano K, Sakai N, Matsuzawa Y.
    Biochim Biophys Acta; 2000 Dec 15; 1529(1-3):257-75. PubMed ID: 11111094
    [Abstract] [Full Text] [Related]

  • 5. A hyperalphalipoproteinaemic family with normal cholesteryl ester transfer/exchange activity.
    Groener JE, da Col PG, Kostner GM.
    Biochem J; 1987 Feb 15; 242(1):27-31. PubMed ID: 3593240
    [Abstract] [Full Text] [Related]

  • 6. Molecular mechanisms, lipoprotein abnormalities and atherogenicity of hyperalphalipoproteinemia.
    Yamashita S, Maruyama T, Hirano K, Sakai N, Nakajima N, Matsuzawa Y.
    Atherosclerosis; 2000 Oct 15; 152(2):271-85. PubMed ID: 10998455
    [Abstract] [Full Text] [Related]

  • 7. Molecular mechanisms of cholesteryl ester transfer protein deficiency in Japanese.
    Nagano M, Yamashita S, Hirano K, Takano M, Maruyama T, Ishihara M, Sagehashi Y, Kujiraoka T, Tanaka K, Hattori H, Sakai N, Nakajima N, Egashira T, Matsuzawa Y.
    J Atheroscler Thromb; 2004 Oct 15; 11(3):110-21. PubMed ID: 15256762
    [Abstract] [Full Text] [Related]

  • 8. The interaction of cholesteryl ester transfer protein and unesterified fatty acids promotes a reduction in the particle size of high-density lipoproteins.
    Barter PJ, Chang LB, Newnham HH, Rye KA, Rajaram OV.
    Biochim Biophys Acta; 1990 Jun 28; 1045(1):81-9. PubMed ID: 2369588
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Small polydisperse low density lipoproteins in familial hyperalphalipoproteinemia with complete deficiency of cholesteryl ester transfer activity.
    Yamashita S, Matsuzawa Y, Okazaki M, Kako H, Yasugi T, Akioka H, Hirano K, Tarui S.
    Atherosclerosis; 1988 Mar 28; 70(1-2):7-12. PubMed ID: 3355618
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Large and cholesteryl ester-rich high-density lipoproteins in cholesteryl ester transfer protein (CETP) deficiency can not protect macrophages from cholesterol accumulation induced by acetylated low-density lipoproteins.
    Ishigami M, Yamashita S, Sakai N, Arai T, Hirano K, Hiraoka H, Kameda-Takemura K, Matsuzawa Y.
    J Biochem; 1994 Aug 28; 116(2):257-62. PubMed ID: 7822240
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [New approach to pathogenesis of genetic hyperlipoproteinemias].
    Koizumi J, Inazu A, Mabuchi H.
    Rinsho Byori; 1993 May 28; 41(5):519-26. PubMed ID: 8350515
    [Abstract] [Full Text] [Related]

  • 15. Increased plasma apolipoprotein E-rich high-density lipoprotein and its effect on serum high-density lipoprotein cholesterol determination in patients with familial hyperalphalipoproteinemia due to cholesteryl ester transfer activity deficiency.
    Chiba H, Eto M, Fujisawa S, Akizawa K, Intoh S, Miyata O, Noda K, Matsuno K, Kobayashi K.
    Biochem Med Metab Biol; 1993 Feb 28; 49(1):79-89. PubMed ID: 8439452
    [Abstract] [Full Text] [Related]

  • 16. Compound heterozygote of cholesteryl-ester transfer protein deficiency in a patient with hyperalphalipoproteinemia.
    Takegoshi T, Haba T, Kitoh C, Inazu A, Koizumi J, Mabuchi H, Takeda R.
    Atherosclerosis; 1992 Sep 28; 96(1):83-5. PubMed ID: 1418105
    [No Abstract] [Full Text] [Related]

  • 17. Genetic cholesteryl ester transfer protein deficiency is extremely frequent in the Omagari area of Japan. Marked hyperalphalipoproteinemia caused by CETP gene mutation is not associated with longevity.
    Hirano K, Yamashita S, Nakajima N, Arai T, Maruyama T, Yoshida Y, Ishigami M, Sakai N, Kameda-Takemura K, Matsuzawa Y.
    Arterioscler Thromb Vasc Biol; 1997 Jun 28; 17(6):1053-9. PubMed ID: 9194754
    [Abstract] [Full Text] [Related]

  • 18. Prevalence and phenotypic spectrum of cholesteryl ester transfer protein gene mutations in Japanese hyperalphalipoproteinemia.
    Maruyama T, Sakai N, Ishigami M, Hirano K, Arai T, Okada S, Okuda E, Ohya A, Nakajima N, Kadowaki K, Fushimi E, Yamashita S, Matsuzawa Y.
    Atherosclerosis; 2003 Jan 28; 166(1):177-85. PubMed ID: 12482565
    [Abstract] [Full Text] [Related]

  • 19. Mechanisms of enhanced cholesteryl ester transfer from high density lipoproteins to apolipoprotein B-containing lipoproteins during alimentary lipemia.
    Tall A, Sammett D, Granot E.
    J Clin Invest; 1986 Apr 28; 77(4):1163-72. PubMed ID: 3958185
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.